Global /China /Healthcare /Drug Manufacturers - General /002868

Lifecome Biochemistry Co.,Ltd.

002868

• SHE: 002868 • Delayed

38.82CNY 1.3%

5.74 USD

As of 14 June 2026, Lifecome Biochemistry Co.,Ltd. has a market cap of $879.37M USD, ranking #11466 globally and #3324 in China. It ranks #1040 in the Healthcare sector, and #389 in the Drug Manufacturers - General industry.

Global Rank

11466

Country Rank

3324

Sector Rank

1040

Industry Rank

389

Key Stats

Market Cap

$879.37MUSD

5.96B CNY

Enterprise Value

$921.41MUSD

6.24B CNY

Revenue (TTM)

$74.22MUSD

502.95M CNY

EBITDA (TTM)

$6.56MUSD

44.36M CNY

Net Income (TTM)

-$15.31MUSD

-103.75M CNY

EBITDA Margin

8.8%

Profit Margin

-21%

PS Ratio

11.8

PB Ratio

83.8

EV/EBITDA

136.8

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Jing Yang open_in_new

Employees

549

Founded

2003

Website

pclifecome.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
1.3%	-3.3%	0.7%	8.3%	35%	14%	128%	13%	206%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	002868 绿康生化股份有限公司 Class A ISIN: CNE100002QH2 Shares Out.: Shares Outstanding: 155.416M¹ Shares Float: 55.555M² TV: TradingView: SZSE: 002868 SA: Stock Analysis: SHE: 002868 YF: Yahoo Finance: 002868.SZ GF: Google Finance: SHE: 002868 BA: Barron's: 002868 MS: Morningstar: XSHE: 002868	38.82 CNY	TV: TradingView: SZSE: 002868 SA: Stock Analysis: SHE: 002868 YF: Yahoo Finance: 002868.SZ GF: Google Finance: SHE: 002868 BA: Barron's: 002868 MS: Morningstar: XSHE: 002868

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Lifecome Biochemistry Co.,Ltd.

Lifecome Biochemistry Co.,Ltd. engages in research, development, production, and sales of veterinary drugs in China. It offers probiotics and green microbial functional additives; biopesticides, biofertilizers, and pesticide formulations; and food additives. The company was founded in 2003 and is based in Pucheng, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 6K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 6K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 3K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 2K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 2K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 2K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 87K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 62K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 41K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 36K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 33K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 31K%	20.5	Switzerland

chevron_leftBack